✦ LIBER ✦

Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer

✍ Scribed by Noboru Yamanaka; Tetsuo Himi; Yasuaki Harabuchi; Katsuhumi Hoki; Akikatsu Kataura

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 563 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19881101)62:9<1932::aid-cncr2820620911>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of cancer testis antigens in

Expression of cancer testis antigens in head and neck squamous cell carcinomas

✍ David L. A. Figueiredo; Rui C. M. Mamede; Rodrigo Proto-Siqueira; Luciano Neder; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

## Abstract ## Background. There is considerable interest in the expression of cancer testis (CT) antigens in human cancers, because they may serve as the basis for diagnostic tests or an immunologic approach to therapy, or as prognostic markers. ## Methods. On this basis, we evaluated by semiqu

Efficacy of neck treatment in patients w

Efficacy of neck treatment in patients with head and neck squamous cell carcinoma

✍ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the

Cell-mediated immune response in head an

Cell-mediated immune response in head and neck cancer patients

✍ Dr. A. Olivari; R. Pradier; J. Feierstein; A. Guardo; H. Glait; A. Rojas 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB

## Abstract The immune reactivity of 100 head and neck cancer patients was studied by means of DNCB, candidine, blastic transformation with PHA, and lymphocyte counts. DNCB reactivity was strong in only 21% of the population and was found impaired in patients with advanced primitive tumors, with m

Second primary tumors in patients with h

Second primary tumors in patients with head and neck squamous cell carcinoma

✍ Eliezer Robinson; Alfred I. Neugut; A. S. Jones 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 2 views

Radioimmunotherapy in patients with head

Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience

✍ David R. Colnot; Jasper J. Quak; Jan C. Roos; Remco de Bree; Abraham J. Wilhelm; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Abstract ## Background Despite improvements in locoregional treatment of stages III/IV squamous cell carcinoma of the head and neck (HNSCC), local and distant failure rates remain high. An effective adjuvant therapy is required for these patients. Among novel approaches is radioimmunotherapy, i

Circulating immune complexes and chemoth

Circulating immune complexes and chemotherapy response in patients with head and neck cancer

✍ Beverly A. Blazar; Dr. Marvin P. Fried; Marshall Strome; John R. Clark; Patricia 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

An assay which could prospectively predict a response to chemotherapy prior to instituting therapy would be beneficial, especially for nonresponders. We evaluated at random a total of 50 patients with previously untreated stage 111 and IV head and neck squamous cell carcinoma for T-cell subsets and